Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Virtus LifeSci Biotech Products ETF
Similar ETFs
Trading data
BBP performance and flow charts
Performance
Flows
Historic performance and flows
Data as of March 9, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +3.56% | +10.97% | +7.12% | +43.58% | +78.58% | +59.76% |
| Flows | +$4M | +$16M | +$4M | +$19M | +$19M | +$9M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +24.63% | +25.52% | +23.63% | +26.14% |
Max drawdown | -7.42% | -17.97% | -25.54% | -38.24% |
Max drawdown duration | 32d | 106d | 292d | 915d |
Time to recover | 19d | 92d | 144d | 583d |
Replication quality
Data as of February 27, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
Exposure
Data as of January 31, 2026Countries
Sectors
Diversification
Total weight of top 15 holdings out of 63
Top 15 Holdings
Characteristics
The Virtus LifeSci Biotech Products ETF is built to track the LifeSci Biotechnology Products Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly).
This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Provider | VIRTUS Investment Partners |
| N° of holdings | 63 |
| Replication method | Direct (Physical) |
| Asset class | Equities |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | December 16, 2014 |
| ESG | No |
What type of ETF is BBP?
BBP is a Passive ETF that provides exposure to Equity assets. It is managed by VIRTUS Investment Partners.
What index does BBP track?
BBP tracks the LifeSci Biotechnology Products Total Return Index - USD, aiming to replicate its performance through full replication.
What does BBP invest in?
This ETF provides exposure to Equally Weighted US Equities. It is part of the segment: Tomorrow's Treatments.
What is the expense ratio of BBP?
The total expense ratio (TER) of BBP is 0.79%, representing the annual fee charged by the fund manager.
When was BBP launched?
BBP was launched on December 16, 2014, marking its entry into the ETF market.
Who is the issuer of BBP?
BBP is issued by VIRTUS Investment Partners.
What is the AUM of BBP?
As of March 9, 2026, BBP manages $51.26 M, reflecting the total assets held in the fund.
How has BBP performed recently?
As of March 9, 2026, BBP delivered a return of 3.56% over the past month (1M performance), 10.97% over the past three months (3M), and 7.12% year-to-date (YTD).
What are the recent fund flows for BBP?
As of March 9, 2026, BBP has seen net flows of +$4M in the past month (1M flow) and +$4M year-to-date (YTD).
How many holdings are in BBP
As of January 31, 2026, BBP holds 63 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is BBP?
As of January 31, 2026, BBP holds 63 securities, with 30.11% of its assets concentrated in its top 15 holdings.
What are the top holdings of BBP?
As of January 31, 2026, BBP holds a portfolio of 63 underlyings, with its largest positions including DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does BBP invest in?
As of January 31, 2026, BBP has its largest geographic exposures in USA.
What sectors or themes does BBP focus on?
As of January 31, 2026, BBP is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
